CN Stock MarketDetailed Quotes

000504 Landfar Bio-medicine

Watchlist
  • 6.75
  • -0.18-2.60%
Not Open Jun 3 15:00 CST
2.23BMarket Cap-76704P/E (TTM)

Landfar Bio-medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
-25.23%25.97M
-31.72%136.79M
-33.02%104.76M
-35.84%70.43M
-46.40%34.74M
27.92%200.35M
52.40%156.4M
62.87%109.78M
95.64%64.82M
-10.79%156.62M
Operating revenue
-25.23%25.97M
-31.72%136.79M
-33.02%104.76M
-35.84%70.43M
-46.40%34.74M
27.92%200.35M
52.40%156.4M
62.87%109.78M
95.64%64.82M
-10.79%156.62M
Other operating revenue
----
-94.05%348.83K
----
-95.75%240.86K
----
7,157.19%5.86M
----
--5.66M
----
-39.12%80.81K
Total operating cost
-16.29%29.98M
-24.07%157.38M
-25.74%113.19M
-31.32%75.77M
-46.82%35.81M
18.15%207.27M
40.69%152.42M
56.49%110.32M
115.47%67.35M
12.69%175.43M
Operating cost
-15.29%9.21M
-38.07%43.69M
-43.43%34.37M
-52.26%23.71M
-69.38%10.87M
54.41%70.54M
282.60%60.75M
338.53%49.67M
565.75%35.5M
-41.49%45.68M
Operating tax surcharges
1.83%217.54K
8.77%1.22M
0.43%780.81K
8.94%495.48K
17.21%213.64K
-13.68%1.12M
-9.53%777.44K
-24.34%454.8K
-56.36%182.27K
10.80%1.3M
Operating expense
-15.21%7.41M
-36.45%38.4M
-24.63%27.7M
-25.46%18.42M
-34.33%8.74M
4.77%60.43M
-12.63%36.75M
-7.93%24.72M
4.92%13.31M
53.35%57.68M
Administration expense
-10.47%10.59M
-2.26%52.39M
-4.24%36.58M
-0.70%24.31M
-7.97%11.82M
11.13%53.6M
15.87%38.2M
15.33%24.48M
37.27%12.85M
57.95%48.23M
Financial expense
-81.12%370.99K
-21.37%9.11M
-24.55%6.83M
-32.95%4.46M
-46.12%1.96M
-17.17%11.59M
-9.44%9.05M
10.44%6.65M
87.94%3.65M
324.81%13.99M
-Interest expense (Financial expense)
-74.11%709.47K
-14.20%11.07M
-23.23%7.65M
-22.62%5.21M
-29.90%2.74M
-8.59%12.9M
-14.90%9.97M
-13.68%6.73M
11.35%3.91M
251.80%14.11M
-Interest Income (Financial expense)
52.13%-418.68K
-32.06%-2.35M
-29.58%-1.7M
-58.01%-1.39M
-118.41%-874.56K
27.80%-1.78M
35.54%-1.31M
48.19%-880.89K
75.63%-400.42K
-1,672.36%-2.46M
Research and development
-0.60%2.18M
25.86%12.57M
0.63%6.94M
0.47%4.36M
18.71%2.2M
16.88%9.99M
4.83%6.9M
-2.91%4.34M
22.10%1.85M
71.68%8.54M
Credit Impairment Loss
----
-35.67%-33.47M
-560.59%-2.44M
-571.02%-2.44M
----
-40.74%-24.67M
150.01%528.85K
148.90%517.13K
----
-441.74%-17.53M
Asset Impairment Loss
----
-227.38%-6.94M
-100.90%-2.36K
-727.78%-2.36K
----
26.00%-2.12M
--263.12K
---285
----
-359.25%-2.86M
Other net revenue
68.62%1.53M
-30.66%-25.12M
201.82%13.3M
-146.47%-1.07M
2,810.90%908.55K
-62.25%-19.23M
1,105.13%4.41M
409.75%2.31M
-108.53%-33.51K
-1,156.76%-11.85M
Fair value change income
-468.36%-88.72K
156.35%33.18K
46.80%-213.83K
71.65%-82.3K
95.58%-15.61K
62.13%-58.88K
-242.80%-401.92K
-185.02%-290.25K
-428.24%-353.44K
47.96%-155.49K
Invest income
531.74%1.36M
23,776.68%920.55K
656.15%787.24K
311.57%576.55K
177.42%214.73K
102.46%3.86K
-66.83%-141.55K
-66.82%-272.51K
-999.65%-277.35K
-315.86%-156.82K
-Including: Investment income associates
----
86.04%-68.51K
95.37%-4.42K
95.37%-4.42K
----
-51.54%-490.9K
59.06%-95.47K
59.06%-95.47K
----
25.66%-323.94K
Asset deal income
----
13,973.43%11.9M
18,436.73%13.77M
-173.03%-54.25K
----
186.18%84.59K
1,491.40%74.27K
1,491.71%74.28K
----
-98.44%29.56K
Other revenue
-62.77%264.12K
-67.78%2.43M
-65.80%1.4M
-59.30%926.83K
18.78%709.42K
-14.65%7.53M
394.03%4.08M
290.13%2.28M
37.50%597.27K
604.75%8.83M
Operating profit
-1,389.25%-2.48M
-74.82%-45.71M
-42.00%4.87M
-463.60%-6.41M
93.51%-166.24K
14.73%-26.15M
236.54%8.39M
145.89%1.76M
-212.89%-2.56M
-261.87%-30.67M
Add:Non operating Income
----
-78.28%1.01M
-78.37%1.01M
-78.43%1M
761.12%1M
485.41%4.63M
43.27%4.65M
2,341.67%4.64M
1,662.43%116.13K
159.93%791.29K
Less:Non operating expense
51.77%1.82K
-95.45%1.93K
-94.58%1.89K
-92.60%1.2K
-81.84%1.2K
-88.03%42.37K
-89.74%34.87K
-93.01%16.19K
6,153.48%6.6K
26.21%353.87K
Total profit
-397.58%-2.48M
-107.38%-44.71M
-54.87%5.87M
-184.66%-5.41M
133.96%832.56K
28.68%-21.56M
501.89%13.01M
264.54%6.38M
-207.75%-2.45M
-259.36%-30.23M
Less:Income tax cost
-6.52%368.97K
-73.80%2.07M
-76.05%1.16M
-83.42%415.92K
-49.79%394.69K
174.94%7.9M
128.54%4.85M
107.76%2.51M
35.68%786.1K
-33.67%2.87M
Net profit
SL-2.85M
FPtoL-46.78M
-42.29%4.71M
SL-5.82M
FLtoP437.87K
FPtoL-29.46M
FLtoP8.16M
FLtoP3.88M
SL-3.24M
SL-33.1M
Net profit from continuing operation
-750.09%-2.85M
-58.79%-46.78M
-42.29%4.71M
-250.16%-5.82M
113.52%437.87K
11.00%-29.46M
252.31%8.16M
176.20%3.88M
-290.93%-3.24M
-326.17%-33.1M
Less:Minority Profit
-103.14%-75.88K
-9.44%-18.61M
-44.58%4.22M
84.34%3.15M
171.05%2.41M
-21.66%-17M
150.30%7.62M
41.18%1.71M
-560.02%-3.4M
-315.63%-13.98M
Net profit of parent company owners
-40.21%-2.77M
-126.15%-28.17M
-9.99%486.72K
-514.10%-8.97M
-1,335.77%-1.98M
34.87%-12.46M
106.44%540.72K
134.40%2.17M
-83.29%159.9K
-334.54%-19.13M
Earning per share
Basic earning per share
-33.33%-0.0084
-125.00%-0.09
-5.88%0.0016
-511.43%-0.0288
-1,360.00%-0.0063
33.33%-0.04
106.30%0.0017
134.65%0.007
-83.87%0.0005
-300.00%-0.06
Diluted earning per share
-33.33%-0.0084
-125.00%-0.09
-5.88%0.0016
-511.43%-0.0288
-1,360.00%-0.0063
33.33%-0.04
106.30%0.0017
134.65%0.007
-83.87%0.0005
-300.00%-0.06
Other composite income
Total composite income
-750.09%-2.85M
-58.79%-46.78M
-42.29%4.71M
-250.16%-5.82M
113.52%437.87K
11.00%-29.46M
252.31%8.16M
176.20%3.88M
-290.93%-3.24M
-326.17%-33.1M
Total composite income of parent company owners
-40.21%-2.77M
-126.15%-28.17M
-9.99%486.72K
-514.10%-8.97M
-1,335.77%-1.98M
34.87%-12.46M
106.44%540.72K
134.40%2.17M
-83.29%159.9K
-334.54%-19.13M
Total composite income of minority owners
-103.14%-75.88K
-9.44%-18.61M
-44.58%4.22M
84.34%3.15M
171.05%2.41M
-21.66%-17M
150.30%7.62M
41.18%1.71M
-560.02%-3.4M
-315.63%-13.98M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue -25.23%25.97M-31.72%136.79M-33.02%104.76M-35.84%70.43M-46.40%34.74M27.92%200.35M52.40%156.4M62.87%109.78M95.64%64.82M-10.79%156.62M
Operating revenue -25.23%25.97M-31.72%136.79M-33.02%104.76M-35.84%70.43M-46.40%34.74M27.92%200.35M52.40%156.4M62.87%109.78M95.64%64.82M-10.79%156.62M
Other operating revenue -----94.05%348.83K-----95.75%240.86K----7,157.19%5.86M------5.66M-----39.12%80.81K
Total operating cost -16.29%29.98M-24.07%157.38M-25.74%113.19M-31.32%75.77M-46.82%35.81M18.15%207.27M40.69%152.42M56.49%110.32M115.47%67.35M12.69%175.43M
Operating cost -15.29%9.21M-38.07%43.69M-43.43%34.37M-52.26%23.71M-69.38%10.87M54.41%70.54M282.60%60.75M338.53%49.67M565.75%35.5M-41.49%45.68M
Operating tax surcharges 1.83%217.54K8.77%1.22M0.43%780.81K8.94%495.48K17.21%213.64K-13.68%1.12M-9.53%777.44K-24.34%454.8K-56.36%182.27K10.80%1.3M
Operating expense -15.21%7.41M-36.45%38.4M-24.63%27.7M-25.46%18.42M-34.33%8.74M4.77%60.43M-12.63%36.75M-7.93%24.72M4.92%13.31M53.35%57.68M
Administration expense -10.47%10.59M-2.26%52.39M-4.24%36.58M-0.70%24.31M-7.97%11.82M11.13%53.6M15.87%38.2M15.33%24.48M37.27%12.85M57.95%48.23M
Financial expense -81.12%370.99K-21.37%9.11M-24.55%6.83M-32.95%4.46M-46.12%1.96M-17.17%11.59M-9.44%9.05M10.44%6.65M87.94%3.65M324.81%13.99M
-Interest expense (Financial expense) -74.11%709.47K-14.20%11.07M-23.23%7.65M-22.62%5.21M-29.90%2.74M-8.59%12.9M-14.90%9.97M-13.68%6.73M11.35%3.91M251.80%14.11M
-Interest Income (Financial expense) 52.13%-418.68K-32.06%-2.35M-29.58%-1.7M-58.01%-1.39M-118.41%-874.56K27.80%-1.78M35.54%-1.31M48.19%-880.89K75.63%-400.42K-1,672.36%-2.46M
Research and development -0.60%2.18M25.86%12.57M0.63%6.94M0.47%4.36M18.71%2.2M16.88%9.99M4.83%6.9M-2.91%4.34M22.10%1.85M71.68%8.54M
Credit Impairment Loss -----35.67%-33.47M-560.59%-2.44M-571.02%-2.44M-----40.74%-24.67M150.01%528.85K148.90%517.13K-----441.74%-17.53M
Asset Impairment Loss -----227.38%-6.94M-100.90%-2.36K-727.78%-2.36K----26.00%-2.12M--263.12K---285-----359.25%-2.86M
Other net revenue 68.62%1.53M-30.66%-25.12M201.82%13.3M-146.47%-1.07M2,810.90%908.55K-62.25%-19.23M1,105.13%4.41M409.75%2.31M-108.53%-33.51K-1,156.76%-11.85M
Fair value change income -468.36%-88.72K156.35%33.18K46.80%-213.83K71.65%-82.3K95.58%-15.61K62.13%-58.88K-242.80%-401.92K-185.02%-290.25K-428.24%-353.44K47.96%-155.49K
Invest income 531.74%1.36M23,776.68%920.55K656.15%787.24K311.57%576.55K177.42%214.73K102.46%3.86K-66.83%-141.55K-66.82%-272.51K-999.65%-277.35K-315.86%-156.82K
-Including: Investment income associates ----86.04%-68.51K95.37%-4.42K95.37%-4.42K-----51.54%-490.9K59.06%-95.47K59.06%-95.47K----25.66%-323.94K
Asset deal income ----13,973.43%11.9M18,436.73%13.77M-173.03%-54.25K----186.18%84.59K1,491.40%74.27K1,491.71%74.28K-----98.44%29.56K
Other revenue -62.77%264.12K-67.78%2.43M-65.80%1.4M-59.30%926.83K18.78%709.42K-14.65%7.53M394.03%4.08M290.13%2.28M37.50%597.27K604.75%8.83M
Operating profit -1,389.25%-2.48M-74.82%-45.71M-42.00%4.87M-463.60%-6.41M93.51%-166.24K14.73%-26.15M236.54%8.39M145.89%1.76M-212.89%-2.56M-261.87%-30.67M
Add:Non operating Income -----78.28%1.01M-78.37%1.01M-78.43%1M761.12%1M485.41%4.63M43.27%4.65M2,341.67%4.64M1,662.43%116.13K159.93%791.29K
Less:Non operating expense 51.77%1.82K-95.45%1.93K-94.58%1.89K-92.60%1.2K-81.84%1.2K-88.03%42.37K-89.74%34.87K-93.01%16.19K6,153.48%6.6K26.21%353.87K
Total profit -397.58%-2.48M-107.38%-44.71M-54.87%5.87M-184.66%-5.41M133.96%832.56K28.68%-21.56M501.89%13.01M264.54%6.38M-207.75%-2.45M-259.36%-30.23M
Less:Income tax cost -6.52%368.97K-73.80%2.07M-76.05%1.16M-83.42%415.92K-49.79%394.69K174.94%7.9M128.54%4.85M107.76%2.51M35.68%786.1K-33.67%2.87M
Net profit SL-2.85MFPtoL-46.78M-42.29%4.71MSL-5.82MFLtoP437.87KFPtoL-29.46MFLtoP8.16MFLtoP3.88MSL-3.24MSL-33.1M
Net profit from continuing operation -750.09%-2.85M-58.79%-46.78M-42.29%4.71M-250.16%-5.82M113.52%437.87K11.00%-29.46M252.31%8.16M176.20%3.88M-290.93%-3.24M-326.17%-33.1M
Less:Minority Profit -103.14%-75.88K-9.44%-18.61M-44.58%4.22M84.34%3.15M171.05%2.41M-21.66%-17M150.30%7.62M41.18%1.71M-560.02%-3.4M-315.63%-13.98M
Net profit of parent company owners -40.21%-2.77M-126.15%-28.17M-9.99%486.72K-514.10%-8.97M-1,335.77%-1.98M34.87%-12.46M106.44%540.72K134.40%2.17M-83.29%159.9K-334.54%-19.13M
Earning per share
Basic earning per share -33.33%-0.0084-125.00%-0.09-5.88%0.0016-511.43%-0.0288-1,360.00%-0.006333.33%-0.04106.30%0.0017134.65%0.007-83.87%0.0005-300.00%-0.06
Diluted earning per share -33.33%-0.0084-125.00%-0.09-5.88%0.0016-511.43%-0.0288-1,360.00%-0.006333.33%-0.04106.30%0.0017134.65%0.007-83.87%0.0005-300.00%-0.06
Other composite income
Total composite income -750.09%-2.85M-58.79%-46.78M-42.29%4.71M-250.16%-5.82M113.52%437.87K11.00%-29.46M252.31%8.16M176.20%3.88M-290.93%-3.24M-326.17%-33.1M
Total composite income of parent company owners -40.21%-2.77M-126.15%-28.17M-9.99%486.72K-514.10%-8.97M-1,335.77%-1.98M34.87%-12.46M106.44%540.72K134.40%2.17M-83.29%159.9K-334.54%-19.13M
Total composite income of minority owners -103.14%-75.88K-9.44%-18.61M-44.58%4.22M84.34%3.15M171.05%2.41M-21.66%-17M150.30%7.62M41.18%1.71M-560.02%-3.4M-315.63%-13.98M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg